BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership and Insiders Activity
BRIDGEBIO PHARMA INC (BBIO) is widely held by institutional investors, with 456 firms reporting positions valued at approximately $13.55B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Kohlberg Kravis Roberts & Co. L.P. is the largest disclosed holder, reporting approximately $987.68M in BBIO holdings in its latest filing.
Recent insider activity includes 21 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
456
Total Reported Value
$13.55B
Largest Holder
Kohlberg Kravis Roberts & Co. L.P.
Largest Position
$987.68M
Insider Transactions (90d)
21
Latest Filing Quarter
Q2 2026
New Institutional Positions
83
Funds Exiting Positions
80
Top Institutional Owners
View all- Kohlberg Kravis Roberts & Co. L.P.$987.68M
- Janus Henderson Group Plc$978.61M
- Blackrock, Inc.$766.19M
- Viking Global Investors$741.02M
- Vanguard Capital Management Llc$588.32M
BBIO News
All news- KKR Portfolio Analysis: Significant Changes Observed in Q2 2026
Aug 20, 2026 · valut.ai
- Farallon Capital Management Llc: Recent Investment Activity Analysis
Aug 17, 2026 · valut.ai
Related BBIO Institutional Insights:
- BBIO 13F Institutional Holders
- BBIO Top Institutional Shareholders
- BBIO Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BBIO Insider Trading & SEC Form 4 Activity
- BBIO Articles
- Top Institutional Investor Stock Rankings